These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 2455880)

  • 41. Prognostic characteristics of serum human chorionic gonadotropin titer regression following molar pregnancy.
    Schlaerth JB; Morrow CP; Kletzky OA; Nalick RH; D'Ablaing GA
    Obstet Gynecol; 1981 Oct; 58(4):478-82. PubMed ID: 7279342
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bilateral theca lutein cysts: a rare cause of acute abdomen in pregnancy.
    Upadhyaya G; Goswami A; Babu S
    Emerg Med Australas; 2004; 16(5-6):476-7. PubMed ID: 15537414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hydatidiform moles.
    Heath JM; Bu TH; Brereton WF
    Am Fam Physician; 1985 May; 31(5):123-31. PubMed ID: 2581433
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disappearance of serum progesterone: after normal delivery and removal of hydatidiform mole.
    Dawood MY; Teoh ES
    Obstet Gynecol; 1975 Jan; 45(1):9-12. PubMed ID: 1110825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early detection of persistent trophoblastic tumour by serum human chorionic gonadotrophin monitoring after molar pregnancy.
    Ngan HY; Wong LC
    Chin Med J (Engl); 1999 Mar; 112(3):260-3. PubMed ID: 11593563
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral contraceptives and postmolar trophoblastic disease.
    Berkowitz RS; Goldstein DP; Marean AR; Bernstein M
    Obstet Gynecol; 1981 Oct; 58(4):474-7. PubMed ID: 6269038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia.
    Rotmensch J; Rosenshein NB; Block BS
    Gynecol Oncol; 1988 Jan; 29(1):82-6. PubMed ID: 2448190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
    Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
    Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enormously enlarged ovaries due to multiple theca-lutein cysts associated with chorioadenoma destruens.
    Csapó Z; Zámbó Z; Csömör S; Berbik I; Treit S
    Patol Pol; 1979; 30(2):203-9. PubMed ID: 225713
    [No Abstract]   [Full Text] [Related]  

  • 52. Partial hydatidiform mole with false-negative urine human chorionic gonadatropin test in the emergency department.
    Mundangepfupfu T; Waseem M
    J Emerg Med; 2014 Mar; 46(3):348-50. PubMed ID: 24188605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy.
    Feltmate CM; Growdon WB; Wolfberg AJ; Goldstein DP; Genest DR; Chinchilla ME; Lieberman ES; Berkowitz RS
    J Reprod Med; 2006 Nov; 51(11):902-6. PubMed ID: 17165438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Molar pregnancy (primary or recurrent?)].
    Ayala A; Aizpuru E; Tovar JM
    Ginecol Obstet Mex; 1989 Aug; 57():226-8. PubMed ID: 2562106
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Partial Invasive Mole with Bilateral Torsion of Theca Lutein Cysts.
    Yadav RS; Shrestha S; Sharma S; Singh M; Bista KD; Ojha N
    J Nepal Health Res Counc; 2018 Jan; 15(3):298-300. PubMed ID: 29353908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum free estriol and estriol glucuronide fractions in hydatidiform mole measured by radioimmunoassay.
    Dawood MY; Brown JB; Newnam KL
    Obstet Gynecol; 1977 Mar; 49(3):303-7. PubMed ID: 840458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Testosterone in the molar vesicle fluid and theca-lutein cyst fluid.
    Chew PC; Ratnam SS; Goh HH
    Br J Obstet Gynaecol; 1978 Mar; 85(3):218-20. PubMed ID: 629902
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of low risk of persistent trophoblastic disease in molar pregnancies.
    Niemann I; Petersen LK; Hansen ES; Sunde L
    Obstet Gynecol; 2006 May; 107(5):1006-11. PubMed ID: 16648403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Guidelines following hydatidiform mole: a reappraisal.
    Kerkmeijer L; Wielsma S; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum relaxin in patients with hydatidiform mole.
    Seki K; Uesato T; Tabei T; Kato K
    Obstet Gynecol; 1986 Mar; 67(3):381-3. PubMed ID: 3945450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.